- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT02550990
Synergistic Effects of Aerobic Exercise and Cognitive Training on Cognition in Stroke Patients With Cognitive Decline
Synergistic Effects of Aerobic Exercise and Cognitive Training on Cognition, Physiological Markers, Daily Function and Quality of Life in Stroke Patients With Cognitive Decline
Studienübersicht
Status
Bedingungen
Studientyp
Einschreibung (Voraussichtlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
-
Chiayi City, Taiwan, 613
- Rekrutierung
- Chiayi Chang Gung Memorial Hospital
-
Kontakt:
- Shi-Zhe Lin, MS
- Telefonnummer: 2688 +886-5-3621000
- E-Mail: apirlline@cgmh.org.tw
-
Kaohsiung City, Taiwan, 83301
- Rekrutierung
- Kaohsiung Chang Gung Memorial Hospital
-
Kontakt:
- Ku-Chou Chang, MD
- Telefonnummer: 2285 +886-7317123
- E-Mail: kcchang@cgmh.org.tw
-
Keelung City, Taiwan, 204
- Rekrutierung
- Keeling Chang Gung Memorial Hospital
-
Kontakt:
- Chia-Ling Chen, PhD
- Telefonnummer: 8147 +886-3-3281200
- E-Mail: ccl1374@adm.cgmh.com.tw
-
Taipei City, Taiwan, 105
- Rekrutierung
- Taipei Chang Gung Memorial Hospital
-
Kontakt:
- Chia-Ling Chen, PhD
- Telefonnummer: 8147 +886-3-3281200
- E-Mail: ccl1374@adm.cgmh.com.tw
-
Taoyuan City, Taiwan, 333
- Rekrutierung
- Taoyuan Chang Gung Memorial Hospital
-
Kontakt:
- Chia-Ling Chen, PhD
- Telefonnummer: 8147 +886-3-3281200
- E-Mail: ccl1374@adm.cgmh.com.tw
-
-
Taoyuan
-
Kwei-Shan, Taoyuan, Taiwan, 333
- Rekrutierung
- Chang Gung Memorial Hospital
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Ischemic or hemorrhagic stroke occurring at least 6 months prior to enrollment
- Age range from 20 to 90 years
- MMSE score ≥ 19
- MoCA<26
- Self- or informant-reported memory or cognitive complaints or CDR scale ≤ 0.5
- Able to follow the study instruction
- Adequate cardiopulmonary function to perform aerobic exercise
- Able to walk with or without assistive devices
Exclusion Criteria:
- Unstable medical history (e.g., recent myocardial infarction) that might limit participation
- Concomitant with other neurological disorders (e.g., Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis)
- Current participation in another interventional trial
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Aktiver Komparator: Cognitive training group
One 60-min session of cognitive training.
Before and after the treatment, a total of 2 evaluations were conducted, including clinical assessments and blood test (each 18c.c.).
A saliva sample (2 mL) will only be collected once from each subject.
A follow-up assessment of clinical outcomes will be conducted at six month after the end of the course of treatment.
|
|
|
Aktiver Komparator: Aerobic exercise training group
One 60-min session of aerobic exercise training.
Before and after the treatment, a total of 2 evaluations were conducted, including clinical assessments and blood test (each 18c.c.).
A saliva sample (2 mL) will only be collected once from each subject.
A follow-up assessment of clinical outcomes will be conducted at six month after the end of the course of treatment.
|
|
|
Experimental: Sequential training group
One 30-min session of aerobic exercise training + one 30-min session of cognitive training. Before and after the treatment, a total of 2 evaluations were conducted, including clinical assessments and blood test (each 18c.c.). A saliva sample (2 mL) will only be collected once from each subject. A follow-up assessment of clinical outcomes will be conducted at six month after the end of the course of treatment. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change scores of Montreal Cognitive Assessment (MoCA)
Zeitfenster: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Wechsler Memory Scale - Third Edition (WMS-III)
Zeitfenster: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Wechsler Adult Intelligence Scale - Third Edition (WAIS-III)
Zeitfenster: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Useful Field of View (UFOV)
Zeitfenster: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Stroop Color-Word test
Zeitfenster: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Dual-task test
Zeitfenster: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
The dual-task tests will be assessed to determine the ability for an individual to perform 2 tasks simultaneously.
The investigators will assess the dual-task performance during walking and performing box and block test.
The results of the dual-task tests will provide information regarding to whether the 2 tasks compete for the same class of neural resources or one of the tasks can be carried out automatically.
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Ändern Sie die Werte des antioxidativen Markers
Zeitfenster: Baseline, Posttest (ein erwarteter Durchschnitt von 3 Monaten)
|
Antioxidative Marker werden verwendet, um die Veränderungen des oxidativen Stresses widerzuspiegeln.
Insbesondere werden wir die Gesamtantioxidationskapazität (TAC) analysieren.
|
Baseline, Posttest (ein erwarteter Durchschnitt von 3 Monaten)
|
|
Ändern Sie die Werte des Plasmalipidspiegels
Zeitfenster: Baseline, Posttest (ein erwarteter Durchschnitt von 3 Monaten)
|
Das Cholesterinverhältnis (Gesamtcholesterin geteilt durch hochdichtes Lipid) wird ausgewertet, um den Lipidspiegel im Blut widerzuspiegeln.
|
Baseline, Posttest (ein erwarteter Durchschnitt von 3 Monaten)
|
|
Change scores of serum BDNF level
Zeitfenster: Baseline, posttest (an expected average of 3 months)
|
Baseline, posttest (an expected average of 3 months)
|
|
|
Change scores of Glucose indicator
Zeitfenster: Baseline, posttest (an expected average of 3 months)
|
HbA1C level will be tested to investigate the relationships between blood glucose level and aerobic exercise.
|
Baseline, posttest (an expected average of 3 months)
|
|
Change scores of Functional Independence Measure (FIM)
Zeitfenster: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Lawton Instrumental Activities of Daily Living Scale (Lawton IADL)
Zeitfenster: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Stroke Impact Scale (SIS)
Zeitfenster: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Caregiver Burden (CB) scale
Zeitfenster: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of EuroQol (EQ)-5D questionnaire
Zeitfenster: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Timed up and go test (TUG)
Zeitfenster: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Six-minute walk test (6MWT)
Zeitfenster: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Mobility level
Zeitfenster: Baseline, posttest (an expected average of 3 months)
|
Baseline, posttest (an expected average of 3 months)
|
|
|
Change scores of International Physical Activity Questionnaires (IPAQ)
Zeitfenster: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Fugl-Meyer Assessment (FMA)
Zeitfenster: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Rivermead Mobility Index (RMI)
Zeitfenster: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of muscle strength
Zeitfenster: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
We will evaluate isometric knee flexors and extensors muscle strength using handheld dynamometer.
Also, we will use hand dynamometer to measure grip strength of the affected and less affected hand while the participant is seated, with the elbow at 90-degree flexion.
We will record the mean value of 3 attempts.
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
Change scores of Community Integration Questionnaire (CIQ)
Zeitfenster: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Geriatric Depression Scale (GDS)
Zeitfenster: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Genotyping of the BDNF val66met polymorphism
Zeitfenster: Between baseline and posttest (an expected average of 3 months)
|
Between baseline and posttest (an expected average of 3 months)
|
Mitarbeiter und Ermittler
Sponsor
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Gibson E, Koh CL, Eames S, Bennett S, Scott AM, Hoffmann TC. Occupational therapy for cognitive impairment in stroke patients. Cochrane Database Syst Rev. 2022 Mar 29;3(3):CD006430. doi: 10.1002/14651858.CD006430.pub3.
- Yeh TT, Wu CY, Hsieh YW, Chang KC, Lee LC, Hung JW, Lin KC, Teng CH, Liao YH. Synergistic effects of aerobic exercise and cognitive training on cognition, physiological markers, daily function, and quality of life in stroke survivors with cognitive decline: study protocol for a randomized controlled trial. Trials. 2017 Aug 31;18(1):405. doi: 10.1186/s13063-017-2153-7.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Voraussichtlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 104-4892A3
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Kognitives Training
-
San Diego State UniversityUniversity of California, San DiegoAbgeschlossen
-
Maastricht University Medical CenterBeendetÜberfütterung und BewegungNiederlande
-
University of California, San DiegoAbgeschlossenAutismus-Spektrum-Störung | Autistische StörungVereinigte Staaten
-
Northeastern UniversityOregon Health and Science University; University of California, RiversideRekrutierung
-
Karolinska InstitutetRegion Stockholm; Stiftelsen Sunnerdahls Handikappfond; Swedish Foundation for... und andere MitarbeiterAbgeschlossenAufmerksamkeitsdefizitsyndromSchweden
-
Umeå UniversityKarlstad UniversityRekrutierungParkinson Krankheit | Kognitive BeeinträchtigungSchweden
-
Taichung Veterans General HospitalAbgeschlossen
-
Bambino Gesù Hospital and Research InstituteRekrutierungKindheitsfettleibigkeit | Adipositas und Übergewicht | LeptinresistenzItalien
-
VA Office of Research and DevelopmentAbgeschlossenParkinson-Krankheit | Leichte kognitive EinschränkungVereinigte Staaten
-
Riphah International UniversityAbgeschlossenSportphysiotherapiePakistan